Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
31.45499
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
under $11k
0
12,363
8,496.1641
6,908.94922
7.5
black
26.796875
38
0.868896
0.822998
1
1
0
no
0.6
0.5
no dnr
7
131
11
103
10
37.69531
96
3
1.299805
2.699707
144
7.429688
392
53
924
null
null
adl>=4 (>=5 if sur)
2.064941
198
1
35.60797
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
>$50k
0
55,312
30,751.875
35,774.4062
23
white
20.5
24
0.912964
0.880981
1
0
0
no
1
0.95
no dnr
19
139
null
106
28
35.59375
219.03125
3.299805
0.5
8.398438
137
7.449219
92
53
325
null
0
no(M2 and SIP pres)
0
685
0
76.18896
female
0
3
COPD
COPD/CHF/Cirrhosis
4
null
null
0
4,601
2,396.1289
2,195.38867
null
white
13
8
0.856934
0.763916
1
0
1
yes
null
null
dnr before sadm
-1
65
12.5
60
30
37.69531
126.51562
3.099609
null
1.5
140
7.429688
210
52
800
null
null
null
4.192383
685
0
83.07495
female
0
17
Coma
Coma
1
14
$11-$25k
37
25,394
15,203.2812
15,030.9531
13.666664
white
17.097656
18
0.371948
0.297974
1
0
0
metastatic
0.5
0.2
dnr before sadm
-1
38
39.398438
52
14
38.69531
354
2.799805
0.399963
7.799805
130
7.329102
63
63
0
null
2
<2 mo. follow-up
2
29
1
81.00995
male
0
10
Lung Cancer
Cancer
1
16
null
0
12,735
6,927.9883
7,069.69922
14
white
16
24
0.690918
0.399963
1
0
0
metastatic
0.1
0
dnr after sadm
2
72
10.599609
103
12
36.39844
241.65625
2.699707
0.399963
0.699951
143
7.40918
292
26
1,375
null
3
<2 mo. follow-up
3
16
1
52.11798
male
0
37
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
141,717
95,230
80,719.75
39
black
24.097656
43
0.824951
0.765991
3
1
0
no
0.3
0.3
no dnr
37
53
6.5
60
24
36.59375
161.21875
2.799805
null
0.699951
135
7.469727
99
7
1,275
null
null
null
2.054688
682
0
89.547
female
0
12
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
16,186
8,523.2422
8,228.25781
15.5
white
21.597656
42
0.746948
0.600952
1
0
0
no
0.6
0.5
no dnr
12
75
14
74
24
35.89844
276.1875
null
null
1.5
136
7.449219
106
22
3,750
1
3
adl>=4 (>=5 if sur)
3
141
1
90.03094
male
0
14
CHF
COPD/CHF/Cirrhosis
3
null
>$50k
0
19,286
9,880.3359
10,211.0078
7
white
17.597656
23
0.80896
0.690918
1
0
0
no
0.7
0.6
dnr after sadm
6
83
11.298828
100
20
35.39844
null
2.099609
3.699707
0.899902
131
null
96
11
750
0
0
<2 mo. follow-up
0
32
1
78.00696
female
0
9
Colon Cancer
Cancer
2
8
$11-$25k
0
9,633
5,673.2227
5,506.94922
13.5
white
28.699219
10
0.545898
0.222992
1
0
0
metastatic
0.9
0.9
no dnr
9
57
11.699219
70
10
38.19531
176
2.299805
0.5
2.699707
132
7.359375
141
63
2,170
1
1
no(M2 and SIP pres)
1
212
1
74.771
female
1
29
ARF/MOSF w/Sepsis
ARF/MOSF
4
14
$25-$50k
0
144,316
96,597.3125
80,722.375
39.5
hispanic
33.796875
52
0.482971
0.363953
1
0
0
yes
0.3
0.2
dnr after sadm
15
54
117
118
30
38.19531
null
null
null
0.5
137
7.429688
105
23
930
null
0
<2 mo. follow-up
0
29
1
79.82794
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
null
0
16,884
9,903.6406
9,306.90625
16
white
19.898438
33
0.814941
0.753906
1
0
0
no
0.95
0.9
no dnr
10
57
8.798828
60
20
38.29688
141.65625
3
1
1.199951
137
7.379883
129
17
4,600
0
null
no(M2 and SIP pres)
0.494751
680
0
48.55899
male
0
4
CHF
COPD/CHF/Cirrhosis
4
14
$25-$50k
0
4,980
2,690.5996
3,391.92969
9
white
18.199219
17
0.891968
0.819946
1
0
0
yes
null
null
no dnr
4
100
3.699707
60
25
36.09375
null
null
null
2.799805
143
null
89
70
1,600
null
null
no(M2 and SIP pres)
2.184082
680
0
68.65399
male
0
38
ARF/MOSF w/Sepsis
ARF/MOSF
2
15
null
0
98,707
null
null
34.5
black
27.398438
32
0.737915
0.655884
1
1
0
no
0.9
0.7
no dnr
38
60
10
110
12
38.5
180
2.299805
0.599976
2.199707
148
7.359375
106
46
2,044
null
0
adl>=4 (>=5 if sur)
0
158
1
20.05199
female
0
13
Cirrhosis
COPD/CHF/Cirrhosis
1
13
under $11k
0
27,570
16,774.4219
15,263.875
11.5
asian
28.597656
37
0.866943
0.779907
1
0
0
no
0.6
0.5
no dnr
13
82
17
120
30
38.09375
135
null
null
1
137
7.449219
373
30
1,500
0
0
null
0
678
0
51.86298
male
0
49
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
193,178
116,287.625
102,016.438
48
white
33.695313
62
0.612915
0.506958
11
0
0
no
0.2
0.1
no dnr
49
63
4.799805
38
26
36.19531
null
null
0.699951
1.899902
140
null
98
78
1,890
null
0
no(M2 and SIP pres)
0
677
0
85.85895
male
0
10
COPD
COPD/CHF/Cirrhosis
2
10
under $11k
0
14,731
8,202.5156
7,041.92969
16.5
white
20.796875
24
0.726929
0.573975
1
0
1
no
null
null
dnr after sadm
1
73
2.599609
180
4
36.59375
140
2.299805
4.399414
2.699707
136
7.359375
97
49
750
null
7
adl>=4 (>=5 if sur)
7
677
0
72.24597
female
0
7
Lung Cancer
Cancer
4
12
$11-$25k
0
10,505
5,559.7383
5,308.29688
7
white
20.296875
41
0.615967
0.301941
1
1
0
metastatic
0.8
0.6
no dnr
7
77
8.199219
73
8
37.69531
165
null
null
1
140
7.429688
102
22
4,000
0
0
<2 mo. follow-up
0
27
1
70.26996
female
0
16
CHF
COPD/CHF/Cirrhosis
4
12
$25-$50k
0
15,786
9,205.1953
8,086.22656
12
white
21
26
0.792969
0.667969
1
1
0
yes
0.6
0.5
dnr after sadm
5
131
13.099609
120
7
38
240.8125
null
0.599976
2.5
143
7.269531
114
52
399
2
0
null
0
259
1
74.87195
female
0
4
Lung Cancer
Cancer
1
12
null
0
4,868
2,726.8789
2,120.68945
7
white
15.398438
14
0.715942
0.436951
1
0
0
metastatic
null
null
dnr after sadm
1
112
10.699219
118
40
39.19531
266.625
2.399902
1.799805
1.699951
141
7.459961
144
14
3,100
null
null
<2 mo. follow-up
2.908691
5
1
59.65198
male
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
4
10
$11-$25k
0
70,523
37,017.0938
33,704.9688
34.333313
white
22
29
0.829956
0.771973
3
1
0
no
null
null
no dnr
17
123
9.099609
80
20
37.59375
433.3125
3.299805
0.899902
5.199219
122
7.289062
943
64
null
null
null
no(M2 and SIP pres)
2.557129
675
0
66.34595
female
0
11
COPD
COPD/CHF/Cirrhosis
3
14
>$50k
0
12,506
6,952.1836
8,685.125
11.5
white
13.898438
27
0.887939
0.812988
1
0
0
yes
1
1
no dnr
11
108
7.5
114
8
38.39844
185
3
null
0.599976
139
7.40918
75
9
4,895
1
2
no(M2 and SIP pres)
2
675
0
58.60898
female
0
24
COPD
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
76,228
58,941.125
48,895
30
white
38.796875
49
0.584961
0.391968
1
0
0
no
0.7
0.6
no dnr
24
83
14.599609
80
20
36.69531
412
3.899902
0.299988
0.899902
146
7.329102
124
31
null
null
4
no(M2 and SIP pres)
4
674
1
83.13794
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
under $11k
9
13,636
7,885.5391
6,766.62891
12
white
22.296875
46
0.738892
0.657959
1
0
1
no
0.95
0.8
no dnr
10
75
null
67
20
36.19531
null
null
null
1.399902
136
null
108
17
1,475
null
null
adl>=4 (>=5 if sur)
5.370117
326
1
93.89496
male
0
7
COPD
COPD/CHF/Cirrhosis
5
null
null
0
8,276
4,589.8164
5,258.36719
4
white
18.597656
18
0.636963
0.455994
1
0
0
yes
0.65
0.5
no dnr
7
117
7.199219
100
20
38.69531
420
4.199219
0.5
0.799927
132
7.539062
133
11
1,200
null
null
null
4.414063
114
1
63.55899
male
0
4
COPD
COPD/CHF/Cirrhosis
2
6
under $11k
0
3,814
2,211.6289
2,215.64844
9
white
14.699219
26
0.91394
0.85498
1
0
0
no
0.95
0.9
no dnr
4
113
12.099609
80
20
36.69531
null
3.599609
1.199951
1.599854
140
null
110
51
null
3
null
no(M2 and SIP pres)
2.510742
670
0
88.10699
male
0
11
CHF
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
11,812
6,656.2422
6,744.65625
11
white
21.597656
20
0.753906
0.610962
1
0
0
no
0.75
0.6
no dnr
11
123
17.898438
70
12
36.79688
160
2.199707
null
1.899902
148
7.389648
362
52
2,360
1
1
no(M2 and SIP pres)
1
670
0
88.65198
male
1
12
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
0
34,155
21,667.0938
19,497.7656
31
white
38.296875
54
0.339966
0.223999
1
1
1
no
0.2
0.1
dnr after sadm
1
107
12.398438
80
25
36.09375
272
null
0.599976
2.099609
144
7.319336
103
50
1,400
null
null
<2 mo. follow-up
6.161133
12
1
78.18195
female
0
13
Lung Cancer
Cancer
2
11
under $11k
9
11,763
7,217.9141
6,539.1875
11
white
32.5
19
0.208984
0.021
1
0
0
metastatic
0.2
0.05
dnr after sadm
1
97
7.799805
80
25
36.09375
460
null
null
1.399902
136
7.469727
184
39
1,250
null
6
<2 mo. follow-up
6
27
1
76.01398
male
0
7
COPD
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
10,143
5,317.5781
5,798.20703
7
white
20.097656
19
0.806885
0.68689
1
0
0
no
null
null
no dnr
7
83
24.699219
80
15
36.09375
null
2.599609
0.699951
0.799927
134
null
148
11
982
1
null
no(M2 and SIP pres)
1.166748
669
0
91.71796
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
4
6
under $11k
0
52,128
38,784.875
30,594.6875
26.333328
white
25.5
57
0.645996
0.544922
2
1
0
no
0.7
0.6
dnr after sadm
11
43
15.5
113
16
37.79688
154
1.899902
0.099991
0.899902
146
7.299805
186
14
1,338
null
2
adl>=4 (>=5 if sur)
2
668
0
60.78
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
>$50k
0
46,709
28,562.625
26,098.1562
13.333328
white
23.597656
49
0.748901
0.669922
4
0
0
yes
0.75
0.75
no dnr
14
59
10.099609
78
28
37.89844
150
3.699707
0.699951
1
142
7.459961
114
26
2,064
0
0
no(M2 and SIP pres)
0
668
0
48.87299
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
54,664
28,733.1094
32,420.1562
24
white
22.699219
32
0.845947
0.792969
4
0
0
no
0.98
0.98
no dnr
9
104
9.398438
108
22
36.59375
null
null
null
1.299805
140
null
133
23
2,990
0
0
no(M2 and SIP pres)
0
392
1
49.45398
female
0
4
Lung Cancer
Cancer
2
12
$25-$50k
0
12,241
6,169.6445
2,776.16992
11
white
9.199219
12
0.853882
0.67688
1
0
0
metastatic
0.8
0.5
no dnr
4
49
5.699219
107
28
38.89844
287.5
null
0.599976
1.399902
142
7.429688
110
35
2,710
0
null
no(M2 and SIP pres)
0.494751
664
0
75.33698
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
30,832
21,063.1719
20,832.3438
46.5
white
41.59375
57
0.333984
0.218994
1
0
0
no
0.3
0.2
dnr after sadm
2
72
15.099609
128
14
36.29688
null
2
4.099609
0.599976
131
null
164
10
1,200
null
6
<2 mo. follow-up
6
7
1
36.44897
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
9,396
6,253.5547
6,516.72656
12
white
26.199219
30
0.862915
0.814941
1
0
0
no
0.9
0.7
no dnr
6
60
29.796875
150
12
36.09375
66
1.699951
1.099854
0.799927
145
7.329102
309
11
965
0
null
null
0.494751
661
0
74.48297
male
1
31
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
55
53,352
38,328.8125
35,363
18.5
white
22.898438
45
0.48999
0.371948
2
0
0
yes
null
0
dnr after sadm
1
57
5
80
20
36.29688
261.875
2.799805
null
1
144
7.389648
105
9
null
null
0
<2 mo. follow-up
0
31
1
90.84998
female
0
8
CHF
COPD/CHF/Cirrhosis
5
16
$25-$50k
0
13,773
7,660.4609
7,365.83984
17
white
18
30
0.750977
0.60791
1
1
0
yes
null
null
no dnr
8
80
16.898438
80
20
36.09375
300
3.299805
1.099854
1.099854
133
7.459961
158
47
500
1
0
no(M2 and SIP pres)
0
369
1
58.70999
male
0
21
Lung Cancer
Cancer
2
null
null
0
46,753
22,374.1719
26,309.3594
14.333328
white
22.597656
20
0.598999
0.280945
1
0
0
metastatic
0.9
0.5
no dnr
21
103
6.699219
70
20
35.59375
null
null
null
2.299805
138
null
151
79
3,050
6
null
null
4.527344
231
1
79.76495
female
0
4
CHF
COPD/CHF/Cirrhosis
3
12
null
0
4,730
2,543.9805
2,328.37891
9
white
22.097656
43
0.782959
0.652954
1
1
0
no
null
null
no dnr
4
77
3.5
90
20
37.79688
290.4375
null
null
0.599976
143
7.509766
107
11
null
null
null
no(M2 and SIP pres)
2.429688
660
0
61.133
male
0
4
CHF
COPD/CHF/Cirrhosis
3
14
$11-$25k
0
4,455
2,464.0703
2,166.2793
7
white
20.898438
26
0.863892
0.773926
1
0
0
no
0.99
0.99
no dnr
4
60
16.898438
120
12
38.39844
186
null
null
1.199951
138
7.429688
196
12
1,138
0
null
no(M2 and SIP pres)
0.494751
658
0
92.28497
male
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
32,367
22,582.9531
18,268.5781
15
white
33.195313
56
0.377991
0.258972
1
0
1
yes
0.5
0.3
dnr before sadm
-1
109
9.798828
104
12
37.59375
168
1.899902
3.799805
1.099854
143
7.379883
137
25
3,430
null
1
<2 mo. follow-up
1
43
1
74.32996
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
$11-$25k
0
78,641
41,373.7188
39,718.4688
15
white
32.398438
52
0.602905
0.495972
1
0
0
no
0.8
0.8
no dnr
19
103
7.5
100
25
36.09375
304.75
4.299805
null
1
142
7.429688
118
21
2,575
null
0
no(M2 and SIP pres)
0
657
0
89.00195
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
$11-$25k
0
16,165
8,656.2188
12,441.0078
14.5
white
23.398438
28
0.7229
0.637939
1
0
0
no
0.75
0.6
no dnr
9
75
14.298828
120
22
36.59375
295.1875
2.899902
0.599976
2.399902
133
7.5
114
38
2,200
0
0
no(M2 and SIP pres)
0
657
0
74.71295
female
0
5
COPD
COPD/CHF/Cirrhosis
1
12
under $11k
0
6,499
3,311.8633
3,244.13867
12
white
19.398438
19
0.823975
0.712891
1
0
0
no
null
null
no dnr
5
46
13.398438
128
32
36.09375
216
null
null
0.699951
127
7.289062
268
19
1,610
0
null
no(M2 and SIP pres)
0.494751
657
0
83.68195
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
$11-$25k
61
16,292
12,585.8359
9,766.38281
30
white
16.296875
17
0.67395
0.578979
1
0
0
no
0.2
0.05
dnr after sadm
3
53
31.5
65
22
36.09375
98.32812
3
0.5
0.899902
140
7.469727
80
36
725
null
1
<2 mo. follow-up
1
5
1
84.71698
female
1
10
Cirrhosis
COPD/CHF/Cirrhosis
2
14
null
0
11,188
6,340.8047
6,025.9375
10
white
15.298828
30
0.714966
0.556885
1
0
0
no
0.2
0.1
no dnr
10
59
9.898438
68
25
36.09375
262.9375
null
null
1.699951
150
7.389648
131
69
1,070
null
0
<2 mo. follow-up
0
10
1
75.05499
female
0
7
COPD
COPD/CHF/Cirrhosis
3
9
under $11k
0
10,896
5,416.8984
5,122.20703
9
white
14.398438
37
0.876953
0.795898
1
0
0
no
0.9
0.6
no dnr
7
97
3.599609
56
20
36.29688
320
3.199707
null
0.899902
141
7.399414
89
26
725
2
1
<2 mo. follow-up
1
56
1
75.51294
male
0
6
Colon Cancer
Cancer
4
10
$11-$25k
0
10,102
5,214.3555
4,136.67969
12
white
32.59375
46
0.44696
0.135986
1
1
0
metastatic
0.6
0.5
dnr after sadm
3
93
9.798828
80
20
37
340
null
null
0.899902
146
7.389648
110
37
58.695312
2
1
<2 mo. follow-up
1
9
1
69.95197
female
0
6
CHF
COPD/CHF/Cirrhosis
6
12
$25-$50k
0
8,304
5,138.1016
4,948.04688
16
white
16.5
26
0.881958
0.803955
1
1
0
no
0.8
0.75
no dnr
6
70
6.199219
80
20
36.09375
383.3125
2.599609
0.699951
1.299805
148
7.439453
120
36
1,650
1
1
no(M2 and SIP pres)
1
651
0
42.198
male
0
4
ARF/MOSF w/Sepsis
ARF/MOSF
5
11
under $11k
26
8,124
5,598.8945
4,661.22656
22
other
25.199219
65
0.802979
0.737915
1
0
0
no
0.7
0.65
dnr after sadm
2
53
21.398438
125
34
38.29688
125
3
1
2.399902
152
7.439453
420
55
2,661
null
null
<2 mo. follow-up
2.992676
24
1
52.099
male
0
19
Cirrhosis
COPD/CHF/Cirrhosis
3
12
null
0
32,432
17,322.9219
15,460.4062
15
white
25.5
52
0.748901
0.603882
1
0
0
no
0.75
0.6
dnr after sadm
13
100
13.599609
100
20
36.09375
268
2.299805
null
0.899902
141
7.459961
137
15
null
1
5
no(M2 and SIP pres)
5
634
1
96.55298
female
0
5
CHF
COPD/CHF/Cirrhosis
4
9
under $11k
0
4,872
2,651.5586
2,444.11914
7
white
16.796875
19
0.793945
0.668945
1
0
0
no
0.7
0.6
dnr after sadm
1
103
18.796875
90
25
36.09375
null
null
null
1.399902
138
null
188
29
null
1
null
no(M2 and SIP pres)
1.166748
448
1
60.57999
male
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
3
7
under $11k
0
17,258
12,425.8438
9,322.4375
22
white
24.199219
57
0.81897
0.758911
1
0
0
no
0.9
0.8
no dnr
6
123
5.799805
69
42
39.39844
166
2.399902
null
1.699951
149
7.459961
245
50
1,415
0
0
SIP>=30
0
650
0
77.54999
female
1
22
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
$11-$25k
0
121,358
90,567.5
66,565.25
37
white
37.5
78
0.442993
0.323975
1
0
0
no
0.5
0.5
dnr after sadm
14
121
12.798828
107
24
38.59375
null
3.399902
null
8.898438
133
null
116
106
200
null
0
<2 mo. follow-up
0
22
1
87.93994
female
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
10,547
6,321.6562
6,339.28906
6
white
26.796875
33
0.657959
0.559937
1
1
1
no
null
null
dnr before sadm
-1
123
null
121
24
35.69531
null
null
null
0.899902
141
null
161
18
2,425
null
6
null
6
108
1
80.82098
male
0
33
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
null
44
66,466
41,180.625
33,514.75
22.5
black
19
35
0.60498
0.498962
2
1
1
yes
0.5
0.4
dnr after sadm
16
55
7.699219
72
35
36.89844
171.65625
null
null
0.699951
140
7.419922
112
16
1,470
null
0
adl>=4 (>=5 if sur)
0
160
1
52.405
male
0
15
MOSF w/Malig
ARF/MOSF
2
14
under $11k
0
73,204
51,713.1562
37,489.0625
24.666656
white
31
38
0.483948
0.36499
5
0
0
yes
0.1
0
no dnr
15
63
6.699219
64
20
36.59375
null
4
null
1
142
null
106
9
3,625
null
0
no(M2 and SIP pres)
0
244
1
41.202
female
0
32
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
129,721
82,183.5
56,350.5625
38
white
36.5
71
0.688965
0.595947
1
0
0
no
0.75
0.75
no dnr
32
44
21.898438
105
10
38.5
92
2.699707
null
2.599609
137
7.419922
173
55
953
null
null
null
2.36084
646
0
66.28595
female
0
12
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
0
16,697
9,707.1875
10,306.0625
8.5
white
16.199219
35
0.893921
0.822998
1
0
0
no
0.75
0.5
dnr after sadm
1
47
6.5
80
20
36.09375
504.75
3
0.299988
0.799927
131
7.479492
72
3
1,200
2
1
<2 mo. follow-up
1
43
1
87.06396
female
0
4
COPD
COPD/CHF/Cirrhosis
3
8
$11-$25k
0
5,038
2,673.8769
2,827.80859
9
white
16.796875
18
0.785889
0.656982
1
0
0
no
null
null
dnr after sadm
3
100
6.799805
61
24
36.09375
159.0625
4.299805
0.299988
1.099854
133
7.299805
229
15
1,500
null
null
adl>=4 (>=5 if sur)
3.17627
70
1
29.23999
male
0
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
5,007
2,405.1856
2,665.04883
null
white
22.5
33
0.909912
0.876953
1
0
0
no
null
null
no dnr
3
120
10.5
78
4
38.69531
151
null
null
0.899902
143
7.439453
130
21
1,730
null
null
no(M2 and SIP pres)
1.826416
643
0
62.25299
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
4
19
null
0
47,166
34,499.5625
27,598.8594
29.666656
white
26.597656
48
0.778931
0.706909
1
1
0
no
0.5
0.5
no dnr
16
72
6.599609
80
20
36.59375
385.6875
null
null
1.599854
131
7.429688
118
40
1,730
null
3
SIP>=30
3
642
0
68.75598
male
0
16
COPD
COPD/CHF/Cirrhosis
2
12
null
0
39,370
21,827.7031
19,721.0938
18
white
14.398438
16
0.886963
0.810913
3
0
0
no
0.7
0.6
no dnr
16
78
5
92
12
35.39844
null
3.299805
0.199982
0.599976
140
null
131
5
null
1
1
no(M2 and SIP pres)
1
642
0
47.379
male
0
5
Colon Cancer
Cancer
1
null
null
0
5,139
3,095.4082
4,275.61719
11
white
15.5
14
0.862915
0.69397
1
0
0
metastatic
0.95
0.5
no dnr
5
107
12.398438
60
20
35.39844
290.4375
null
null
1.699951
142
7.369141
53
43
1,300
null
null
null
2.240723
216
1
51.64398
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
2
18
>$50k
0
54,163
35,252
27,047.6562
35.666657
white
42.796875
103
0.379944
0.260986
1
0
0
yes
0.2
0.2
no dnr
16
83
11.298828
120
20
38.19531
null
3.699707
2.299805
1.399902
133
null
97
20
2,400
null
null
no(M2 and SIP pres)
2.358398
640
0
53.02899
male
0
6
Lung Cancer
Cancer
2
12
$11-$25k
0
10,443
5,390.8398
5,308.57812
10
black
19.699219
28
0.681885
0.386963
1
0
0
metastatic
1
0.5
no dnr
6
49
10.699219
60
10
39
220
2.099609
0.699951
4.699219
160
7.349609
150
82
2,000
0
null
<2 mo. follow-up
0.494751
36
1
90.42798
female
0
4
CHF
COPD/CHF/Cirrhosis
4
11
under $11k
0
3,956
2,251.0762
2,230.45898
8
white
17.296875
15
0.810913
0.694946
1
1
0
no
0.95
0.85
no dnr
4
111
11.099609
117
26
36.19531
127
null
null
1.899902
142
7.449219
103
58
1,480
0
null
no(M2 and SIP pres)
0.494751
637
0
76.54797
male
0
7
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
7,034
4,044.625
3,867.28906
10
white
16.597656
24
0.863892
0.774902
1
1
0
no
null
null
no dnr
7
97
6.299805
76
24
36.59375
115
4.199219
0.899902
1.5
137
7.199219
106
26
900
1
0
no(M2 and SIP pres)
0
637
0
80.75
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
$11-$25k
0
45,475
29,121.9219
26,887.3281
29
black
24.296875
41
0.661987
0.563965
16
1
0
no
0.2
0.1
dnr after sadm
1
73
7.5
100
25
36.09375
217.375
null
null
0.899902
141
7.369141
139
16
null
null
0
<2 mo. follow-up
0
5
1
49.68698
male
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$11-$25k
0
48,180
28,100.25
23,259.6562
24
white
33.898438
47
0.699951
0.609985
1
0
0
no
0.78
0.6
no dnr
23
125
13.398438
61
8
38.19531
242.5
3.599609
null
0.799927
140
7.589844
112
14
1,560
0
null
no(M2 and SIP pres)
0.494751
633
0
79.78894
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
0
76,279
43,290.6875
27,250.4219
28.333328
white
16.097656
33
0.809937
0.746948
19
0
0
no
0.7
0.7
no dnr
19
100
9.099609
60
20
37
null
2.399902
0.899902
1.299805
143
null
114
16
280
null
1
no(M2 and SIP pres)
1
632
0
53.58499
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
1
16
>$50k
0
12,397
6,571.5312
5,340.19922
12.5
white
19
31
0.836914
0.733887
1
0
0
no
0.9
0.75
no dnr
8
80
4.299805
70
30
36.09375
228.5625
3.899902
1.099854
1.199951
140
7.379883
152
35
1,075
0
0
no(M2 and SIP pres)
0
632
0
91.01996
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
37
11,767
6,400.082
6,496.94922
18
white
14.699219
21
0.75293
0.674927
1
0
1
no
0.9
0.9
dnr before sadm
-1
73
7.299805
80
20
35.59375
null
2.399902
null
1.699951
132
null
351
61
1,125
null
null
SIP>=30
5.137695
96
1
74.70996
female
1
5
Coma
Coma
1
8
$11-$25k
94
18,728
13,579.5156
11,059.2188
31
white
22.5
30
0.096985
0.057999
2
0
0
yes
0
0
dnr after sadm
4
80
11.398438
80
25
36.69531
276
null
null
1
136
7.479492
227
20
2,525
null
null
<2 mo. follow-up
2.498535
5
1
59.82498
female
0
12
Colon Cancer
Cancer
4
null
null
0
15,538
8,949.1797
6,965.76953
11
null
37.695313
38
0.357971
0.077988
1
0
0
metastatic
0.5
0.25
dnr after sadm
1
53
11.898438
100
15
38.29688
null
1.799805
0.599976
7.299805
138
null
69
68
0
null
null
<2 mo. follow-up
3.479492
18
1
79.49597
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
null
0
37,583
23,426.4375
20,075.7812
20.333328
white
35.195313
52
0.494995
0.377991
1
0
0
no
0.5
0.5
no dnr
15
57
11.699219
80
20
36.09375
null
2.399902
7.399414
1.5
137
null
227
51
null
0
null
no(M2 and SIP pres)
0.494751
629
0
35.17599
male
0
18
MOSF w/Malig
ARF/MOSF
1
14
>$50k
0
86,623
45,066.5312
43,258.9375
21
white
27.199219
52
0.589966
0.480957
10
0
0
yes
0.4
0.2
no dnr
18
107
3
70
30
36.09375
null
null
null
0.899902
140
null
98
16
1,800
0
4
no(M2 and SIP pres)
4
196
1
66.58496
male
0
31
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
124,293
70,849.0625
67,079.6875
40
white
21.597656
42
0.833984
0.776978
1
0
0
no
0.8
0.7
no dnr
31
49
9.898438
70
16
36.09375
371.375
null
0.599976
14.5
135
7.339844
88
83
0
0
1
adl>=4 (>=5 if sur)
1
196
1
86.10797
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
26,338
17,204.7031
14,160.6172
27
white
32.398438
40
0.482971
0.36499
3
0
0
no
0.95
0.85
dnr after sadm
1
111
27.199219
119
10
36
66
2.299805
0.599976
7.199219
135
7.489258
184
79
345
0
1
no(M2 and SIP pres)
1
625
0
75.44696
female
0
32
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
null
0
87,543
62,266.3438
51,062.6562
33
white
32.695313
46
0.586914
0.477966
1
0
1
no
0.5
0.5
dnr after sadm
4
50
6.099609
60
20
35.59375
null
null
null
1.399902
136
null
145
42
null
null
null
null
3.80957
622
0
89.09198
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
14,379
9,627.0469
8,098.1875
8.5
black
21.597656
34
0.699951
0.609985
1
0
0
yes
0.9
0.9
no dnr
7
109
12.398438
72
4
38.79688
295
2.199707
null
1.299805
139
7.429688
274
19
2,160
null
null
null
3.843262
623
0
85.70795
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
$25-$50k
0
55,561
31,941
39,482.3125
33.666657
white
18.597656
36
0.813965
0.751953
1
0
0
no
0.7
0.7
no dnr
18
113
13.199219
110
10
36.09375
91.42188
2.099609
null
0.599976
137
7.429688
180
20
8,550
null
5
adl>=4 (>=5 if sur)
5
623
0
77.23798
male
1
29
MOSF w/Malig
ARF/MOSF
3
15
$11-$25k
0
84,604
49,319.5625
46,697.875
17
hispanic
18.597656
29
0.724976
0.640991
8
0
0
yes
0.8
0.1
dnr after sadm
1
51
2.599609
155
10
38.19531
125
1.599854
1
0.799927
143
7.259766
73
21
2,640
2
1
<2 mo. follow-up
1
29
1
49.875
male
0
16
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
57,210
34,996.625
32,341.1406
30.666656
white
23.097656
34
0.871948
0.786987
1
0
0
no
0.7
0.7
no dnr
16
73
9.298828
70
25
36.69531
260
null
null
0.799927
141
7.359375
213
27
600
null
0
SIP>=30
0
235
1
88.487
female
0
6
CHF
COPD/CHF/Cirrhosis
2
13
under $11k
0
5,350
3,153.6074
3,773.96875
15
white
20.097656
19
0.776978
0.643921
1
0
0
no
0.95
0.6
no dnr
6
73
11.099609
70
20
36.09375
678.25
null
null
1.199951
142
7.279297
155
38
null
2
null
no(M2 and SIP pres)
1.838867
498
1
63.064
male
0
20
COPD
COPD/CHF/Cirrhosis
2
16
$25-$50k
0
44,135
30,358.0156
26,456.7188
22.666656
white
23.398438
24
0.834961
0.730957
1
0
0
no
0.9
0.7
dnr after sadm
1
57
14.599609
124
10
39.09375
368.3125
4.399414
0.5
1
136
7.5
137
11
null
null
0
SIP>=30
0
618
0
77.84296
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
16,510
11,070.5391
10,050.3594
20
white
29
45
0.662964
0.564941
1
1
0
no
0.9
0.8
no dnr
10
67
7.5
73
12
36.29688
152
3.099609
0.399963
5.599609
131
7.389648
317
146
2,745
0
0
no(M2 and SIP pres)
0
618
0
35.13998
female
1
8
MOSF w/Malig
ARF/MOSF
1
15
>$50k
0
134,773
77,402.1875
58,795.5
45.5
white
37.695313
77
0.266968
0.159973
22
0
0
yes
0.5
0.4
dnr after sadm
7
118
8.898438
68
24
39
366.625
null
null
1.399902
140
7.459961
96
26
2,100
null
1
<2 mo. follow-up
1
8
1
77.862
female
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
3
15
$11-$25k
0
50,395
29,363.4375
26,245.6719
23.333328
white
28.597656
35
0.600952
0.493958
1
1
0
yes
0.8
0.65
no dnr
17
69
6.299805
72
20
35.79688
null
null
0.5
1.199951
142
null
106
14
2,875
null
0
no(M2 and SIP pres)
0
448
1
79.59198
female
0
24
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
0
81,465
45,749.0625
43,473.0938
39
white
30.199219
54
0.573975
0.462952
4
0
0
no
0.8
0.8
no dnr
24
111
0.399963
170
28
36.19531
135
2.299805
2.099609
7.799805
135
7.349609
90
103
1,660
null
3
no(M2 and SIP pres)
3
615
0
66.10297
female
0
3
COPD
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
7,201
5,917.7344
4,878.83984
null
black
18.898438
46
0.870972
0.785889
1
1
0
no
0.8
0.7
no dnr
3
87
7.099609
80
20
36.69531
null
null
0.399963
3.5
142
null
88
70
1,375
0
null
no(M2 and SIP pres)
0.494751
204
1
53.55499
female
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
>$50k
0
65,863
47,683.4688
36,288.7188
34
white
23.699219
35
0.845947
0.792969
1
1
0
no
0.9
0.9
no dnr
21
97
7.799805
70
25
36.09375
null
null
null
0.799927
139
null
162
13
1,600
null
1
SIP>=30
1
614
0
61.952
female
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
44
42,843
32,285.8125
26,218.7344
22.333328
null
25.898438
60
0.642944
0.541992
1
0
0
no
0.05
0
dnr after sadm
8
70
3.799805
80
20
35.59375
null
3.899902
null
1.799805
137
null
112
33
null
null
null
<2 mo. follow-up
2.327637
14
1
84.57794
male
0
13
CHF
COPD/CHF/Cirrhosis
2
22
null
0
14,980
8,515
7,564.96875
10.5
white
22.699219
31
0.750977
0.606934
1
0
0
no
0.8
0.5
no dnr
13
63
30.097656
75
24
36.19531
null
2.5
null
5.099609
134
null
303
300
2,155
1
4
SIP>=30
4
613
0
81.06494
male
0
6
CHF
COPD/CHF/Cirrhosis
4
12
>$50k
0
5,775
3,203.0195
3,340.48828
17
white
19.5
17
0.815918
0.701904
1
0
0
no
0.85
0.8
no dnr
6
111
13
110
34
39.59375
162
null
null
1.5
135
7.439453
158
37
3,650
0
null
<2 mo. follow-up
0.494751
36
1
58.168
female
0
5
CHF
COPD/CHF/Cirrhosis
5
12
null
0
6,601
3,433.3731
2,950.85938
18
black
18.898438
35
0.860962
0.770996
1
1
0
yes
0.85
0.85
no dnr
5
110
5.699219
44
34
36.19531
79
2.599609
0.699951
1.899902
138
7.359375
132
27
1,675
1
null
no(M2 and SIP pres)
1.166748
347
1
71.64398
male
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
>$50k
0
49,989
27,934.75
27,841.6719
24
white
29.597656
37
0.572998
0.461975
3
0
0
yes
0.9
0.7
no dnr
17
56
10.5
70
6
37.79688
232.5
2
0.199982
1.199951
143
7.479492
152
21
3,200
null
null
<2 mo. follow-up
2.953613
48
1
63.76999
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
0
22
>$50k
0
69,599
35,332.0312
44,057.0312
22.333328
white
17.398438
33
0.884888
0.843994
1
0
0
no
0.9
0.9
no dnr
18
83
6
80
20
38.29688
null
3
4.5
1.699951
133
null
95
39
800
0
0
no(M2 and SIP pres)
0
548
1
58.60397
male
0
37
MOSF w/Malig
ARF/MOSF
5
22
$25-$50k
0
141,401
91,900.25
73,641.5625
35.25
white
35.898438
48
0.353943
0.237
3
0
0
yes
0.6
0.5
no dnr
37
112
8.398438
76
22
36
null
null
null
1.199951
137
null
93
25
1,325
null
1
adl>=4 (>=5 if sur)
1
563
1
44.49597
female
0
6
Lung Cancer
Cancer
2
12
$25-$50k
0
5,962
3,463.832
4,775.07812
6
black
29.597656
50
0.455994
0.142975
1
0
0
metastatic
0.15
0.01
dnr after sadm
2
116
16.796875
118
32
39.09375
250
4
null
0.799927
145
7.40918
315
18
887
null
null
<2 mo. follow-up
2.540527
16
1